Juvisync Interactions
There are 542 drugs known to interact with Juvisync (simvastatin/sitagliptin), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 60 are major, 473 are moderate, and 9 are minor.
- View all 542 medications that may interact with Juvisync
- View Juvisync alcohol/food interactions (2)
- View Juvisync disease interactions (8)
Most frequently checked interactions
View interaction reports for Juvisync (simvastatin / sitagliptin) and the medicines listed below.
- Accupril (quinapril)
- Accuretic (hydrochlorothiazide / quinapril)
- Aceon (perindopril)
- Acetylsalicylic Acid (aspirin)
- acyclovir
- Advicor (lovastatin / niacin)
- Allegra (fexofenadine)
- Allegra-D 12 Hour (fexofenadine / pseudoephedrine)
- allopurinol
- Altace (ramipril)
- alteplase
- Astelin (azelastine nasal)
- Astepro (azelastine nasal)
- Ativan (lorazepam)
- Atrovent (ipratropium)
- baclofen
- Benadryl (diphenhydramine)
- Capoten (captopril)
- Capozide (captopril / hydrochlorothiazide)
- Cardizem (diltiazem)
- Celexa (citalopram)
- chlorzoxazone
- Clarinex (desloratadine)
- Clarinex-D 12 Hour (desloratadine / pseudoephedrine)
- Claritin (loratadine)
- Claritin-D (loratadine / pseudoephedrine)
- Colace (docusate)
- Coreg (carvedilol)
- doxycycline
- levothyroxine
Juvisync alcohol/food interactions
There are 2 alcohol/food interactions with Juvisync (simvastatin / sitagliptin).
Juvisync disease interactions
There are 8 disease interactions with Juvisync (simvastatin / sitagliptin) which include:
- pancreatitis
- liver disease
- rhabdomyolysis
- renal dysfunction
- renal dysfunction
- cognitive impairment
- diabetes
- renal disease
Report options
QR code containing a link to this page
More about Juvisync (simvastatin / sitagliptin)
- Juvisync consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
